Amnesia

Long COVID: brain function still affected for some up to two years after infection – new research

Retrieved on: 
Wednesday, July 26, 2023

These symptoms are often referred to as “brain fog”, and are especially common among people who have long-term or persistent symptoms called long COVID.

Key Points: 
  • These symptoms are often referred to as “brain fog”, and are especially common among people who have long-term or persistent symptoms called long COVID.
  • COVID infection generally has been linked to an increased risk of being diagnosed with dementia.
  • We found people with persistent symptoms fared worse in these tests up to two years after a COVID infection.

Brain training

    • Another 2,400 completed the second round, of whom 1,700 had also participated in the first round.
    • The tasks aimed to cover a range of elements of brain function, including visual memory, attention, verbal reasoning and motor control.
    • Read more:
      How COVID can disturb your sleep and dreams – and what could help

What we found

    • Digging deeper, we saw that the effect of COVID on test performance was biggest for people with a longer symptom duration of more than three months.
    • These people meet the criteria for having long COVID.
    • By also testing how other factors affected test scores, we were able to put into context how big an impact COVID had.
    • For example, we saw that older people and people experiencing psychological distress scored lower in the tests.

Limitations and where to next

    • It’s important to note some limitations in our study.
    • We don’t have test results for people before their COVID infection, which limited our analysis to comparing results across different groups.

UnitedHealthcare Donates $500,000 To Two Nonprofit Organizations in Minnesota

Retrieved on: 
Tuesday, July 25, 2023

In total, UnitedHealthcare is donating more than $11.1 million in grants through its Empowering Health program across 12 states.

Key Points: 
  • In total, UnitedHealthcare is donating more than $11.1 million in grants through its Empowering Health program across 12 states.
  • The grants will assist people experiencing challenges such as food access and nutrition, social isolation, and behavioral health issues, and support local health education efforts.
  • “UnitedHealthcare is honored to support the important work these local organizations are doing to provide greater access to services for underserved communities in Minnesota,” said Brett Edelson, CEO, UnitedHealthcare of Minnesota.
  • Identifying and addressing social determinants of health needs is a core aspect of how UnitedHealthcare serves its members.

HealthVerity releases the Provider Diversity Index 2023 edition to increase diversity in clinical trials

Retrieved on: 
Tuesday, July 18, 2023

PHILADELPHIA, July 18, 2023 /PRNewswire/ -- HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the science, today announced the release of the Provider Diversity Index (PDI) 2023 edition with breakthrough enhancements that help pharmaceutical manufacturers to prioritize physicians who are treating patients more reflective of the populations impacted by the conditions being studied.

Key Points: 
  • The HealthVerity PDI is being actively used by clients to identify clinical trial site investigators and to more effectively characterize and recruit patient populations that better reflect the diversity mix of diagnosed patients.
  • New enhancements to the HealthVerity PDI for 2023, such as age range, gender, income range, payer type (commercial, Medicare or Medicaid) and diagnosis further the mission of pharmaceutical manufacturers and CROs in achieving their diversity goals.
  • According to the 2020 U.S. Census, 57.8% of the population is White/Caucasian, 12.1% is Black/African American and 18.7% of the population is Hispanic/Latino.
  • "We are proud to have the advanced technologies and privacy techniques to enable our clients to practice better medicine through diversity."

Cumulus Neuroscience Presents Data at AAIC 2023 Annual Meeting and Technology and Dementia Preconference

Retrieved on: 
Monday, July 17, 2023

BELFAST, Northern Ireland and CAMBRIDGE, Mass., July 17, 2023 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, presented interim data from their real-world feasibility study CNS-101 at the Alzheimer's Association International Conference 2023 in Amsterdam, Netherlands.

Key Points: 
  • BELFAST, Northern Ireland and CAMBRIDGE, Mass., July 17, 2023 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, presented interim data from their real-world feasibility study CNS-101 at the Alzheimer's Association International Conference 2023 in Amsterdam, Netherlands.
  • Purely digital markers are scalable but lack objectivity," said Brian Murphy, PhD, Founder and Chief Scientific Officer of Cumulus.
  • Importantly, the remote data captured in this study was of similar quality to data generated using traditional methods in house at Boston University."
  • Dr. Budson and his team receive funding and other resources from Bristol Myers Squibb and Cumulus Neuroscience.

Cumulus Neuroscience Presents Data at AAIC 2023 Annual Meeting and Technology and Dementia Preconference

Retrieved on: 
Monday, July 17, 2023

BELFAST, Northern Ireland and CAMBRIDGE, Mass., July 17, 2023 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, presented interim data from their real-world feasibility study CNS-101 at the Alzheimer's Association International Conference 2023 in Amsterdam, Netherlands.

Key Points: 
  • BELFAST, Northern Ireland and CAMBRIDGE, Mass., July 17, 2023 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, presented interim data from their real-world feasibility study CNS-101 at the Alzheimer's Association International Conference 2023 in Amsterdam, Netherlands.
  • Purely digital markers are scalable but lack objectivity," said Brian Murphy, PhD, Founder and Chief Scientific Officer of Cumulus.
  • Importantly, the remote data captured in this study was of similar quality to data generated using traditional methods in house at Boston University."
  • Dr. Budson and his team receive funding and other resources from Bristol Myers Squibb and Cumulus Neuroscience.

Young-onset Alzheimer’s can be diagnosed from as early as 30 – and the symptoms are often different

Retrieved on: 
Thursday, July 13, 2023

But around 3.9 million people worldwide aged 30-64 live with young-onset Alzheimer’s disease – a form of dementia in which symptoms appear before the age of 65.

Key Points: 
  • But around 3.9 million people worldwide aged 30-64 live with young-onset Alzheimer’s disease – a form of dementia in which symptoms appear before the age of 65.
  • English journalist and broadcaster Fiona Phillips, 62, recently revealed that she’d been diagnosed with it.
  • First, symptoms begin much earlier – as young as 30 in some rare cases, though it’s typically diagnosed between the ages of 50-64.
  • Within the brain itself, young-onset Alzheimer’s disease causes similar chemical changes as those in late-onset Alzheimer’s.

Why it happens

    • For example, poor levels of cardiovascular fitness and lower cognitive ability in early adulthood have been linked to an eight-fold increased risk of developing young-onset Alzheimer’s.
    • One aspect experts are clear on is that genetics play a role in about one in ten cases of young-onset Alzheimer’s disease.
    • Growing evidence suggests there may also be a link between traumatic brain injury and young-onset Alzheimer’s disease.

What can people do?

    • But in the US, two therapies have been approved which may slow the progression of symptoms.
    • However, these were only tested on people with late-onset Alzheimer’s disease, so it’s uncertain if they will have as distinct of an effect.
    • An Italian study found that people who consumed high levels of vegetables, dry fruits and chocolate appeared to have lower risk.

Cumulus Neuroscience Announces Research Collaboration with the Universities of Bath and Bristol on Development of Breakthrough Test for Early Detection of Alzheimer's Dementia

Retrieved on: 
Thursday, July 13, 2023

Dr. Liz Coulthard , Associate Professor in Dementia Neurology at the University of Bristol and neurologist at North Bristol National Health Service (NHS) Trust , is the project co-lead.

Key Points: 
  • Dr. Liz Coulthard , Associate Professor in Dementia Neurology at the University of Bristol and neurologist at North Bristol National Health Service (NHS) Trust , is the project co-lead.
  • Importantly, as a passive test, performance is not impacted by anxiety level, education level or language.
  • They have also demonstrated that this response changes when a person develops dementia, offering hope for its potential as a breakthrough for earlier diagnosis.
  • We are honored to partner with the Universities of Bath and Bristol on this important study."

Cumulus Neuroscience Announces Research Collaboration with the Universities of Bath and Bristol on Development of Breakthrough Test for Early Detection of Alzheimer's Dementia

Retrieved on: 
Thursday, July 13, 2023

Dr. Liz Coulthard , Associate Professor in Dementia Neurology at the University of Bristol and neurologist at North Bristol National Health Service (NHS) Trust , is the project co-lead.

Key Points: 
  • Dr. Liz Coulthard , Associate Professor in Dementia Neurology at the University of Bristol and neurologist at North Bristol National Health Service (NHS) Trust , is the project co-lead.
  • Importantly, as a passive test, performance is not impacted by anxiety level, education level or language.
  • They have also demonstrated that this response changes when a person develops dementia, offering hope for its potential as a breakthrough for earlier diagnosis.
  • We are honored to partner with the Universities of Bath and Bristol on this important study."

IGC Reports Financial Results for Fiscal Year Ended March 31, 2023

Retrieved on: 
Wednesday, July 12, 2023

IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC), a clinical-stage pharmaceutical company, today announced its financial results for the fiscal year ended March 31, 2023 (“Fiscal 2023”).

Key Points: 
  • IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC), a clinical-stage pharmaceutical company, today announced its financial results for the fiscal year ended March 31, 2023 (“Fiscal 2023”).
  • On March 8, 2023, the Company filed a provisional patent application with the USPTO titled “Composition, Synthesis, and Medical Use of Hybrid Cannabinoid”.
  • Ram Mukunda, CEO of IGC, commented, “Fiscal 2023 was characterized by remarkable growth and progress as we continue to advance our drug formulations through FDA trials.
  • Net loss for Fiscal 2023 was approximately $11.5 million or $0.22 per share, compared to approximately $15 million or $0.30 per share for Fiscal 2022.

Drs. Bradley Bale and Amy Doneen Win Two Awards for Book "Healthy Heart, Healthy Brain"

Retrieved on: 
Wednesday, July 12, 2023

SPOKANE, Wash., July 12, 2023 /PRNewswire/ -- Cardiovascular disease (CVD) prevention specialists Bradley Bale, MD and Amy Doneen, DNP have won gold in the prestigious Nautilus Book Awards for 2023 for their book, " Healthy Heart, Healthy Brain: The Personalized Path to Protect Your Memory, Prevent Heart Attacks, and Strokes, and Avoid Chronic Illness ."

Key Points: 
  • SPOKANE, Wash., July 12, 2023 /PRNewswire/ -- Cardiovascular disease (CVD) prevention specialists Bradley Bale, MD and Amy Doneen, DNP have won gold in the prestigious Nautilus Book Awards for 2023 for their book, " Healthy Heart, Healthy Brain: The Personalized Path to Protect Your Memory, Prevent Heart Attacks, and Strokes, and Avoid Chronic Illness ."
  • Coauthored by Lisa Collier Cool, the book also won the American Society for Journalists and Authors' (ASJA) 2023 June Roth Memorial Award for Outstanding Medical Book.
  • Honoring "Better Books for a Better World" in several categories, the Nautilus Book Awards celebrate visionary books aimed at advancing physical, mental, and spiritual healing through positive social action and individual empowerment.
  • Dr. Doneen is also the medical director of The Prevention Center for Heart & Brain Health in Spokane, Washington.